To read the full story
Related Article
- Shionogi Sole Distributor of Nxera’s Insomnia Med in Japan
October 2, 2024
- Japan Panel Clears Amgen’s TED Med, Rexulti for Alzheimer’s Agitation and More
August 28, 2024
- Eisai’s ALS Therapy, Amgen’s TED Drug Up for Review on Aug. 26
August 19, 2024
- Shionogi, Mochida Form Sales Tie-Up for Daridorexant in Japan
November 2, 2023
- Sosei to Acquire Idorsia’s Japan and Korea Arms for 65 Billion Yen
July 21, 2023
- Idorsia’s Insomnia Med Meets PIII Goal in Japan, Filing Planned for H1 2023
October 4, 2022
- Mochida, Idorsia Hook Up on Insomnia Drug in Japan
December 6, 2019
BUSINESS
- Takeda Bags Rights to Keros Therapeutics’ Elritercept
December 5, 2024
- Medipal, JCR Kick Off Japan PI/II of MPS IIIB Therapy
December 4, 2024
- Ono Teams Up with Canada’s Congruence in Cancer Drug Discovery
December 4, 2024
- Australia Accepts Shionogi’s NDA for Antibiotic Cefiderocol
December 4, 2024
- Forxiga Crowned in HP Market Promotion Ranking in October: Intage
December 4, 2024
For 25 years, Morunda has been interviewing leaders in Japan’s pharmaceutical and medical device industry. Most country managers typically come from a commercial background, rooted in sales and marketing. It’s rare to find country managers who come from finance or…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…